Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of active pharmaceutical ingredients (APIs) that require high enantiomeric purity. Its structure supports the development of drugs targeting central nervous system disorders and cardiovascular diseases. Commonly employed in asymmetric synthesis due to the presence of a stereogenic center, enabling the formation of complex molecules with defined spatial orientation. Also utilized in the preparation of peptidomimetics and enzyme inhibitors, where the chlorophenyl group enhances binding affinity and metabolic stability.